Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Nov;76(11):5914–5918. doi: 10.1073/pnas.76.11.5914

Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein.

J E Sealey, S A Atlas, J H Laragh, M Silverberg, A P Kaplan
PMCID: PMC411763  PMID: 42905

Abstract

Plasma prorenin is an inactive form of renin (EC 3.4.99.19) that can be converted to active renin in acid-treated plasma by an endogenous serine protease that is active at alkaline pH (alkaline phase activation). To identify this enzyme we first tested the ability of Hageman factor fragments, plasma kallikrein (EC 3.4.21.8), and plasmin (EC 3.4.21.7) to activate prorenin in acid-treated plasma. All three enzymes initiated prorenin activation; 50% activation was achieved with Hageman factor fragments at 1 microgram/ml, plasma kallikrein at 2-4 microgram/ml, or plasmin at 5-10 microgram/ml. We then showed that the alkaline phase of acid activation occurred normally in plasminogen-free plasma but was almost completely absent in plasmas deficient in either Hageman factor or prekallikrein; alkaline phase activation was restored to these latter plasmas when equal parts were mixed together. Therefore, both Hageman factor and prekallikrein were required for alkaline phase activation to occur. We then found that, although plasma kallikrein could activate prorenin in plasma deficient in either Hageman factor or prekallikrein, Hageman factor fragments were unable to activate prorenin in prekallikrein-deficient plasma. These studies demonstrate that alkaline phase prorenin activation is initiated by Hageman factor-dependent conversion of prekallikrein to kallikrein which, in turn, leads to activation of prorenin. In this fashion, we have revealed a possible link between the coagulation-kinin pathway and the renin-angiotensin system.

Full text

PDF
5914

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atlas S. A., Laragh J. H., Sealey J. E. Activation of inactive plasma renin: evidence that both cryoactivation and acid-activation work by liberating a neutral serine protease from endogenous inhibitors. Clin Sci Mol Med Suppl. 1978 Dec;4:135s–138s. doi: 10.1042/cs055135s. [DOI] [PubMed] [Google Scholar]
  2. Colman R. W. Activation of plasminogen by human plasma kallikrein. Biochem Biophys Res Commun. 1969 Apr 29;35(2):273–279. doi: 10.1016/0006-291x(69)90278-2. [DOI] [PubMed] [Google Scholar]
  3. Colman R. W., Bagdasarian A., Talamo R. C., Scott C. F., Seavey M., Guimaraes J. A., Pierce J. V., Kaplan A. P. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec;56(6):1650–1662. doi: 10.1172/JCI108247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Day R. P., Luetscher J. A., Gonzales C. M. Occurrence of big renin in human plasma, amniotic fluid and kidney extracts. J Clin Endocrinol Metab. 1975 Jun;40(6):1078–1084. doi: 10.1210/jcem-40-6-1078. [DOI] [PubMed] [Google Scholar]
  5. Derkx F. H., Bouma B. N., Schalekamp M. P., Schalekamp M. A. An intrinsic factor XII- prekallikrein-dependent pathway activates the human plasma renin-angiotensin system. Nature. 1979 Jul 26;280(5720):315–316. doi: 10.1038/280315a0. [DOI] [PubMed] [Google Scholar]
  6. Deutsch D. G., Mertz E. T. Plasminogen: purification from human plasma by affinity chromatography. Science. 1970 Dec 4;170(3962):1095–1096. doi: 10.1126/science.170.3962.1095. [DOI] [PubMed] [Google Scholar]
  7. Donaldson V. H., Glueck H. I., Miller M. A., Movat H. Z., Habal F. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis. J Lab Clin Med. 1976 Feb;87(2):327–337. [PubMed] [Google Scholar]
  8. Haas E., Goldblatt H., Gipson E. C. Extraction, purification, and acetylation of human renin and the production of antirenin to human renin. Arch Biochem Biophys. 1965 Jun;110(3):534–543. doi: 10.1016/0003-9861(65)90447-9. [DOI] [PubMed] [Google Scholar]
  9. Kallikrein and plasmin as activators of inactive renin. Lancet. 1978 Dec 23;2(8104-5):1375–1375. [PubMed] [Google Scholar]
  10. Kaplan A. P., Austen K. F. A pre-albumin activator of prekallikrein. J Immunol. 1970 Oct;105(4):802–811. [PubMed] [Google Scholar]
  11. Lincoln T. M., Hall C. L., Park C. R., Corbin J. D. Guanosine 3':5'-cyclic monophosphate binding proteins in rat tissues. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2559–2563. doi: 10.1073/pnas.73.8.2559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Liu C. Y., Scott C. F., Bagdasarian A., Pierce J. V., Kaplan A. P., Colman R. W. Potentiation of the function of Hageman factor fragments by high molecular weight kininogen. J Clin Invest. 1977 Jul;60(1):7–17. doi: 10.1172/JCI108770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lumbers E. R. Activation of renin in human amniotic fluid by low pH. Enzymologia. 1971 Jun 30;40(6):329–336. [PubMed] [Google Scholar]
  14. Mandle R. J., Colman R. W., Kaplan A. P. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov;73(11):4179–4183. doi: 10.1073/pnas.73.11.4179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Mandle R., Jr, Kaplan A. P. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10;252(17):6097–6104. [PubMed] [Google Scholar]
  16. Meier H. L., Pierce J. V., Colman R. W., Kaplan A. P. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest. 1977 Jul;60(1):18–31. doi: 10.1172/JCI108754. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moutoussis G., Klein G. Acute glomerulonephritis preceded by passage of uric-acid calculus. Lancet. 1978 Dec 23;2(8104-5):1376–1377. doi: 10.1016/s0140-6736(78)92010-x. [DOI] [PubMed] [Google Scholar]
  18. Osmond D. H., Cooper R. M. Cryoactivation and tryptic activation of blood 'prorenin' in normal man and animals. Can J Physiol Pharmacol. 1978 Oct;56(5):792–805. doi: 10.1139/y78-125. [DOI] [PubMed] [Google Scholar]
  19. Oza N. B., Ryan J. W. A simple high-yield procedure for isolation of human urinary kallikreins. Biochem J. 1978 Apr 1;171(1):285–288. doi: 10.1042/bj1710285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. RATNOFF O. D., COLOPY J. E. A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma. J Clin Invest. 1955 Apr;34(4):602–613. doi: 10.1172/JCI103109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Revak S. D., Cochrane C. G. The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule. J Clin Invest. 1976 Apr;57(4):852–860. doi: 10.1172/JCI108361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Saito H., Ratnoff O. D., Donaldson V. H. Defective activation of clotting, fibrinolytic, and permeability-enhancing systems in human Fletcher trait plasma. Circ Res. 1974 May;34(5):641–651. doi: 10.1161/01.res.34.5.641. [DOI] [PubMed] [Google Scholar]
  23. Sealey J. E., Atlas S. A., Laragh J. H., Oza N. B., Ryan J. W. Activation of a prorenin-like substance in human plasma by trypsin and by urinary kallikrein. Hypertension. 1979 May-Jun;1(3):179–189. doi: 10.1161/01.hyp.1.3.179. [DOI] [PubMed] [Google Scholar]
  24. Sealey J. E., Atlas S. A., Laragh J. H., Oza N. B., Ryan J. W. Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature. 1978 Sep 14;275(5676):144–145. doi: 10.1038/275144a0. [DOI] [PubMed] [Google Scholar]
  25. Sealey J. E., Moon C., Laragh J. H., Alderman M. Plasma prorenin: cryoactivation and relationship to renin substrate in normal subjects. Am J Med. 1976 Nov;61(5):731–738. doi: 10.1016/0002-9343(76)90154-6. [DOI] [PubMed] [Google Scholar]
  26. Tatemichi S. R., Osmond D. H. Factor XII in endogenous activation of inactive renin. Lancet. 1978 Jun 17;1(8077):1313–1313. doi: 10.1016/s0140-6736(78)91298-9. [DOI] [PubMed] [Google Scholar]
  27. Tewksbury D. A., Frome W. L., Dumas M. L. Characterization of human angiotensinogen. J Biol Chem. 1978 Jun 10;253(11):3817–3820. [PubMed] [Google Scholar]
  28. Thompson R. E., Mandle R., Jr, Kaplan A. P. Association of factor XI and high molecular weight kininogen in human plasma. J Clin Invest. 1977 Dec;60(6):1376–1380. doi: 10.1172/JCI108898. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. WERLE E., MAIER L. Uber die chemische und pharmakologische Unterscheidung von Kallikreinen verschiedener Herkunft. Biochem Z. 1952;323(4):279–283. [PubMed] [Google Scholar]
  30. WU F. C., LASKOWSKI M. Crystalline acid-labile trypsin inhibitor from bovine blood plasma. J Biol Chem. 1960 Jun;235:1680–1685. [PubMed] [Google Scholar]
  31. Weiss A. S., Gallin J. I., Kaplan A. P. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb;53(2):622–633. doi: 10.1172/JCI107597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Wiggins R. C., Bouma B. N., Cochrane C. G., Griffin J. H. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein. Proc Natl Acad Sci U S A. 1977 Oct;74(10):4636–4640. doi: 10.1073/pnas.74.10.4636. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Wuepper K. D., Miller D. R., Lacombe M. J. Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest. 1975 Dec;56(6):1663–1672. doi: 10.1172/JCI108248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Wuepper K. D. Prekallikrein deficiency in man. J Exp Med. 1973 Dec 1;138(6):1345–1355. doi: 10.1084/jem.138.6.1345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Yokosawa N., Takahashi N., Inagami T., Page D. L. Isolation of completely inactive plasma prorenin and its activation by kallikreins. A possible new link between renin and kallikrein. Biochim Biophys Acta. 1979 Aug 15;569(2):211–219. doi: 10.1016/0005-2744(79)90056-1. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES